A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

Outside China, the tirzepatide products are known as Mounjaro ... that its placebo-controlled DREAMs-1 trial of mazdutide in Chinese adults with type 2 diabetes inadequately controlled by diet ...

The former’s Wegovy (semaglutide) product saw sales grow from 2.4 billion in Q4 2022 to 9.6 billion Danish kroner (DKK) in Q3 2023, and Lilly’s Mounjaro (tirzepatide) manage sales of $1.4 ...

At least nine patients using the glucagon-like peptide 1 (GLP-1) receptor agonists semaglutide and tirzepatide developed ophthalmic complications, of whom seven had nonarteritic anterior ischemic ...

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

Jan. 27, 2025 — A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future ... Signposting Children to ...

"Each injection is painful." In the recent study, researchers explored if the diabetes and obesity drug tirzepatide(the active ingredient in Zepbound and Mounjaro) could improve CGL, as it improves ...

Almost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in 2023. These medications, best known by brand names like Ozempic and ...

The primary endpoint of the Phase 2 BMT-801 clinical trial is to demonstrate the safety and efficacy of co-administration of bremelanotide with tirzepatide on reducing body weight. Patients were ...

This Feature (BMJ 2025;388:q2636, doi:10.1136/bmj.q2636, published 3 February 2025) stated that the NICE guidance on tirzepatide was still in draft form. In fact ...